Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy.

@article{Helton2000MetabolicAO,
  title={Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy.},
  author={Erin M. Helton and Robert K. Darragh and Paul Francis and Fredrick J Fricker and Kenneth Jue and Gary Koch and Dora Mair and Mary Ella Pierpont and James V Prochazka and Lawrence S. Linn and Stuart C A Winter},
  journal={Pediatrics},
  year={2000},
  volume={105 6},
  pages={1260-70}
}
OBJECTIVES A multicenter retrospective study was conducted to investigate the possible metabolic causes of pediatric cardiomyopathy and evaluate the outcome of patients treated with L-carnitine. METHODS Seventy-six patients diagnosed with cardiomyopathy were treated with L-carnitine in addition to conventional cardiac treatment, and 145 patients were treated with conventional treatment only. There were 101 males and 120 females between 1 day and 18 years old. Cardiomyopathy diagnoses included… CONTINUE READING